These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

398 related items for PubMed ID: 22846813

  • 1. C3 glomerulopathy: what's in a name?
    D'Agati VD, Bomback AS.
    Kidney Int; 2012 Aug; 82(4):379-81. PubMed ID: 22846813
    [Abstract] [Full Text] [Related]

  • 2. Redefining C3 glomerulopathy: 'C3 only' is a bridge too far.
    Larsen CP, Walker PD.
    Kidney Int; 2013 Feb; 83(2):331-2. PubMed ID: 23364589
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Dense deposit disease and C3 glomerulopathy.
    Barbour TD, Pickering MC, Terence Cook H.
    Semin Nephrol; 2013 Nov; 33(6):493-507. PubMed ID: 24161036
    [Abstract] [Full Text] [Related]

  • 6. Autoimmune abnormalities of the alternative complement pathway in membranoproliferative glomerulonephritis and C3 glomerulopathy.
    Noris M, Donadelli R, Remuzzi G.
    Pediatr Nephrol; 2019 Aug; 34(8):1311-1323. PubMed ID: 29948306
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Toward a working definition of C3 glomerulopathy by immunofluorescence.
    Hou J, Markowitz GS, Bomback AS, Appel GB, Herlitz LC, Barry Stokes M, D'Agati VD.
    Kidney Int; 2014 Feb; 85(2):450-6. PubMed ID: 24067430
    [Abstract] [Full Text] [Related]

  • 12. Cluster Analysis Identifies Distinct Pathogenetic Patterns in C3 Glomerulopathies/Immune Complex-Mediated Membranoproliferative GN.
    Iatropoulos P, Daina E, Curreri M, Piras R, Valoti E, Mele C, Bresin E, Gamba S, Alberti M, Breno M, Perna A, Bettoni S, Sabadini E, Murer L, Vivarelli M, Noris M, Remuzzi G, Registry of Membranoproliferative Glomerulonephritis/C3 Glomerulopathy, Nastasi.
    J Am Soc Nephrol; 2018 Jan; 29(1):283-294. PubMed ID: 29030465
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Changes in the complement system in membranoproliferative glomerulonephritis].
    Yurova VA, Bobrova LA, Kozlovskaya NL, Korotchaeva YV, Serova AG, Kozlov LV, Andina SS, Demyanova KA, Kuchieva AM, Roshchupkina SV.
    Ter Arkh; 2017 Jan; 89(6):69-77. PubMed ID: 28745692
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. C3 glomerulopathy: the genetic and clinical findings in dense deposit disease and C3 glomerulonephritis.
    Xiao X, Pickering MC, Smith RJ.
    Semin Thromb Hemost; 2014 Jun; 40(4):465-71. PubMed ID: 24799308
    [Abstract] [Full Text] [Related]

  • 19. C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up.
    Sethi S, Fervenza FC, Zhang Y, Zand L, Vrana JA, Nasr SH, Theis JD, Dogan A, Smith RJ.
    Kidney Int; 2012 Aug; 82(4):465-73. PubMed ID: 22673887
    [Abstract] [Full Text] [Related]

  • 20. Membranoproliferative glomerulonephritis and C3 glomerulopathy: resolving the confusion.
    Sethi S, Nester CM, Smith RJ.
    Kidney Int; 2012 Mar; 81(5):434-41. PubMed ID: 22157657
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.